title: Effect of recombinant human insulin-like growth factor-I on weight gain, fat content, and hormonal parameters in broiler chickens.
abstract: Osmotic minipumps were implanted in 4-wk-old female broiler chickens to supply a 2-wk continuous infusion of recombinant human insulin-like growth factor-I (rhIGF-I) in three doses (.03, .1, and .3 mg/kg BW per day). At the end of the experimental period no differences in BW were detected, although abdominal fat was significantly reduced in the highest dose group. Measurement of fat content in both breast and thigh muscle indicated a different effect of IGF-I treatment on these parameters, as no reduction was observed. Determination of circulating IGF-I levels revealed a twofold increase in the .3-mg group whereas the lowest dose did not increase circulating plasma levels. The changes in IGF-I levels did not influence growth hormone levels whereas thyroxine levels were significantly decreased both in the .03- and .3-mg groups after 1 wk of treatment. At the same time plasma triiodothyronine levels were increased in the .1- and .3-mg/kg groups. These results indicate that a continuous infusion of IGF-I did not increase weight gain but may play a role as a fat repartitioning agent.
authors.affiliation: Laboratory of Comparative Endocrinology, Leuven, Belgium.
authors.forename: L M
authors.initials: LM
authors.lastname: Huybrechts
authors.forename: E
authors.initials: E
authors.lastname: Decuypere
authors.forename: J
authors.initials: J
authors.lastname: Buyse
authors.forename: E R
authors.initials: ER
authors.lastname: Kühn
authors.forename: M
authors.initials: M
authors.lastname: Tixier-Boichard
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects* / Q000254:growth & development; D000818:Animals; D002645:Chickens / Q000254:growth & development* / Q000378:metabolism; D004435:Eating / Q000187:drug effects; D005260:Female; D013006:Growth Hormone / Q000097:blood; D015918:Infusion Pumps, Implantable / Q000662:veterinary; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D013974:Thyroxine / Q000097:blood*; D014284:Triiodothyronine / Q000097:blood*; D015430:Weight Gain / Q000187:drug effects
chemical_list: D011994:Recombinant Proteins; D014284:Triiodothyronine; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D013974:Thyroxine